Harvard Bioscience, Inc. (HBIO)
8.27
+0.03
(+0.36%)
USD |
NASDAQ |
Oct 13, 16:00
Harvard Bioscience Research and Development Expense (TTM) : 9.094M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.094M |
| March 31, 2026 | 8.83M |
| December 31, 2025 | 8.825M |
| September 30, 2025 | 8.97M |
| June 30, 2025 | 9.405M |
| March 31, 2025 | 9.842M |
| December 31, 2024 | 10.41M |
| September 30, 2024 | 11.23M |
| June 30, 2024 | 11.42M |
| March 31, 2024 | 11.75M |
| December 31, 2023 | 11.76M |
| September 30, 2023 | 11.46M |
| June 30, 2023 | 11.47M |
| March 31, 2023 | 12.01M |
| December 31, 2022 | 12.33M |
| September 30, 2022 | 12.43M |
| June 30, 2022 | 12.33M |
| March 31, 2022 | 11.53M |
| December 31, 2021 | 10.80M |
| September 30, 2021 | 10.20M |
| June 30, 2021 | 9.486M |
| March 31, 2021 | 8.682M |
| December 31, 2020 | 8.685M |
| September 30, 2020 | 8.981M |
| June 30, 2020 | 9.596M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.47M |
| December 31, 2019 | 10.72M |
| September 30, 2019 | 11.12M |
| June 30, 2019 | 11.33M |
| March 31, 2019 | 11.32M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 9.469M |
| June 30, 2018 | 8.224M |
| March 31, 2018 | 6.762M |
| December 31, 2017 | 5.645M |
| September 30, 2017 | 5.275M |
| June 30, 2017 | 5.046M |
| March 31, 2017 | 5.252M |
| December 31, 2016 | 5.392M |
| September 30, 2016 | 5.768M |
| June 30, 2016 | 5.885M |
| March 31, 2016 | 6.097M |
| December 31, 2015 | 6.42M |
| September 30, 2015 | 6.452M |
| June 30, 2015 | 6.085M |
| March 31, 2015 | 5.655M |
| December 31, 2014 | 4.88M |
| September 30, 2014 | 1.614M |
| June 30, 2014 | 2.489M |
| March 31, 2014 | 3.184M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 480.00M |
| Bio-Rad Laboratories, Inc. | 260.70M |
| Bruker Corp. | 393.50M |
| Danaher Corp. | 1.615B |
| Illumina, Inc. | 963.00M |